Alembic Pharma Secures USFDA Tentative Approval for Bosulif Generic Bosutinib 400 mg

Day 1 conference highlights include news from Moderna, BridgeBio

DRRA8 hours ago 0

FDA again rejects tabelecleucel for EBV-driven post-transplant lymphoproliferative disease

DRRA9 hours ago 0

New data, nuances in managing resistant gram-negative infections

DRRA10 hours ago 0

New Year’s resolutions 2026: Lessons from colleagues

DRRA10 hours ago 0